Cargando…
The Rocky Road from Preclinical Findings to Successful Targeted Therapy in Pleural Mesothelioma
Pleural mesothelioma (PM) is a rare and aggressive disease that arises from the mesothelial cells lining the pleural cavity. Approximately 80% of PM patients have a history of asbestos exposure. The long latency period of 20–40 years from the time of asbestos exposure to diagnosis, suggests that mul...
Autores principales: | Paajanen, Juuso, Bueno, Raphael, De Rienzo, Assunta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658134/ https://www.ncbi.nlm.nih.gov/pubmed/36362209 http://dx.doi.org/10.3390/ijms232113422 |
Ejemplares similares
-
Immune Microenvironment and Genetics in Malignant Pleural Mesothelioma
por: Wadowski, Benjamin, et al.
Publicado: (2021) -
Hyperthermic Intrathoracic Chemoperfusion for Malignant Pleural Mesothelioma: Systematic Review and Meta-Analysis
por: Järvinen, Tommi, et al.
Publicado: (2021) -
Evidence for marked underutilization of insurance billing in malignant pleural mesothelioma in Finland
por: Torkki, Paulus, et al.
Publicado: (2021) -
Association of RERG Expression with Female Survival Advantage in Malignant Pleural Mesothelioma
por: De Rienzo, Assunta, et al.
Publicado: (2021) -
Differentially expressed alternatively spliced genes in Malignant Pleural Mesothelioma identified using massively parallel transcriptome sequencing
por: Dong, Lingsheng, et al.
Publicado: (2009)